Lower level of ERβ in intestinal mucosa and peripheral T cells obtained from CD patients, IBD patients in endoscopic activity and IBD patients unresponsive for anti-TNFα therapy was documented. The gene discussed is ESR2; the disease is irritable bowel syndrome.